|
Merial is a multinational animal health company. ==Overview== It was formed in August 1997 as a joint venture between the animal health subsidiaries of Merck & Co. (MSD AgVet) and Sanofi-Aventis (Rhône-Mérieux). Merial is now the animal health subsidiary of Sanofi, formerly known as Sanofi-Aventis. Merial produces many products and vaccines for domestic pets, farm animals and wildlife. Merial has about 6,500 employees and is present in more than 150 countries in the world. Their sales in 2014 were about €2.1 billion. Some of Merial's most popular products are Frontline, Heartgard, Ivomec and Previcox. In October 2009, Merial announced it was investing 70 million US$ at its poultry vaccines plant in Nanchang Hi-tech Development Zone, China. On March 9, 2010, Sanofi-Aventis announced it had exercised an option to combine Merial with Intervet/Schering Plough, the animal health business of Merck. The new joint venture would be equally owned by Merck and Sanofi-Aventis. On March 22, 2011, they announced the mutual termination of their agreement to form a new animal health joint venture. Merial's global headquarters is located at Lyon, France since 2011〔(Merial press release, headquarters moved to Lyon )〕 (after having been located at Duluth, Georgia). 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Merial」の詳細全文を読む スポンサード リンク
|